LOCL-05 CEREBRAL METASTATIC LUNG CARCINOMA: EFFECT OF ALK- AND EGFR-MUTATION STATUS AND SURGICAL MANAGEMENT UPON CLINICAL OUTCOME

PURPOSE: There have been many advancements in the surgical and medical treatment of metastatic lung carcinoma. In the post-genomic era, new directed-oncological therapies such as monoclonal antibodies (mAbs) and tyrosine-kinase inhibitors (TKIs) may offer increased survival for lung carcinoma patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Mannam, Sneha Sai, Bray, David P, Nwagwu, Chibueze D, Goyal, Subir, Deibert, Christopher P, Pradilla, Gustavo, Nduom, Edjah K, Olson, Jeffrey J, Hoang, Kimberly B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354143/
http://dx.doi.org/10.1093/noajnl/vdac078.047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354143/
http://dx.doi.org/10.1093/noajnl/vdac078.047

Ejemplares similares